摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Aminoacetic acid;(3-carboxy-2-propanoyloxypropyl)-trimethylazanium;chloride | 423152-20-9

中文名称
——
中文别名
——
英文名称
2-Aminoacetic acid;(3-carboxy-2-propanoyloxypropyl)-trimethylazanium;chloride
英文别名
2-aminoacetic acid;(3-carboxy-2-propanoyloxypropyl)-trimethylazanium;chloride
2-Aminoacetic acid;(3-carboxy-2-propanoyloxypropyl)-trimethylazanium;chloride化学式
CAS
423152-20-9
化学式
C12H25ClN2O6
mdl
——
分子量
328.79
InChiKey
KNYIDCDOKIOINV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.39
  • 重原子数:
    21
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    130
  • 氢给体数:
    3
  • 氢受体数:
    7

文献信息

  • GEL USEFUL FOR THE DELIVERY OF COSMETIC ACTIVE INGREDIENTS
    申请人:SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A.
    公开号:EP2152225A1
    公开(公告)日:2010-02-17
  • THICKENED AMINO ACID SURFACTANT COMPOSITIONS AND METHODS THEREFOR
    申请人:Lubrizol Advanced Materials, Inc.
    公开号:EP2558525B2
    公开(公告)日:2018-04-04
  • EQUINE NUTRITIONAL SUPPLEMENT
    申请人:Equine Nutriceuticals, LLC
    公开号:EP2665473A2
    公开(公告)日:2013-11-27
  • JP2011001375A
    申请人:——
    公开号:JP2011001375A
    公开(公告)日:2011-01-06
  • Compositions and methods for lowering plasma concentrations of low density lipoproteins in humans
    申请人:Smith L. Michael
    公开号:US20070072910A1
    公开(公告)日:2007-03-29
    The present invention is directed to compositions and method to lower the plasma concentration of a low density lipoprotein in a human. One aspect is the invention is directed to compositions comprising at least one pharmaceutically acceptable L-carnitine compound and at least one pharmaceutically acceptable niacin compound, in such amount as to reduce the concentration of a low density lipoprotein. Another embodiment is directed to a composition of L-carnitine and niacin that substantially reduces side-effects associated with niacin treatment. Another aspect of the invention relates to a method for treating hyperlipidemia while substantially reducing side-effects associated with niacin treatment by administering a composition of L-carnitine and niacin.
查看更多